1. Home
  2. Live Updates
  3. Serum institue

Live Breaking News & Updates on Serum institue

Stay informed with the latest breaking news from Serum institue on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Serum institue and stay connected to the pulse of your community

Ratan Tata Conferred With Maharashtra's First 'Udyog Ratna' Award At His Residence In Mumbai

Ratan Tata Conferred With Maharashtra's First 'Udyog Ratna' Award At His Residence In Mumbai
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Colaba , Maharashtra , India , Mumbai , Devendra-fadnavis , Ratan-tata , Vilas-shinde , Mangal-prabhat-lodha , Adar-poonawalla , Eknath-shinde , Udyog-ratna , Ajit-pawar

The Vial: SII CEO Adar Poonawalla on making Covidshied: 'It was a sense of responsibility of lives & livelihoods'-Entertainment News , Firstpost

Serum Institute collaborated with Oxford University and AstraZeneca to make Covidshield.

China , Thailand , Pune , Maharashtra , India , United-states , Japan , Manoj-bajpayee , Priya-abraham , Adar-poonawalla , Astrazeneca , Oxford-university

Adar Poonawalla - Serum Institue of India's Adar Poonawalla expects Omicron-specific vaccine in six months

SII, the world's biggest vaccine maker, produces AstraZeneca's Covid-19 vaccine under brand name Covishield

India , Astrazeneca-covid , Adar-poonawalla , Serum-institute-of-india , Serum-institue , Chief-executive-officer-adar-poonawalla ,

Covishield vaccine price cut down to Rs 225 from Rs 600, says Serum Institute

Covid,4th wave,COVID cases rise, Maharashtra, Delhi, Coronavirus, covishiled price, covishield price cut down, covishield vaccine, vaccine price, serum institute of india, sii, delhi covid cases, covid vaccination, covid vaccine, covid vaccine price

India , Serum-institute-of-india , Google-news , Image-source , Serum-institue , Covid , 4th-wave , Covid-cases-rise , Aharashtra , Elhi , Oronavirus

Covishield Booster Dose Price in India: End Users Will Have To Pay Rs 600, at Discounted Price in Hospitals, Says SII

The end-users will have to pay Rs 600 for a Covishield booster dose and the hospitals will get it at a discounted price, says Serum Institute of India. 📰 Covishield Booster Dose Price in India: End Users Will Have To Pay Rs 600, at Discounted Price in Hospitals, Says SII.

India , Union-health-ministry-on , Serum-institute-of-india , Serum-institue , Union-health-ministry , Serum-institute , Aadar-poonawala , Ani , Ani-news , Ani-tweets , Booster-dose

'Everyone who needs to travel needs to take COVID-19 booster dose': SII CEO Adar Poonawalla

'Everyone who needs to travel needs to take COVID-19 booster dose': SII CEO Adar Poonawalla

India , Pune , Maharashtra , Adar-poonawalla , Serum-institute-of-india , Serum-institue , Serum-institute , Sii , Serum-institue-of-india , Covid-19-bootser-dose , Covishield ,

DGCI likely to grant market approval for Covaxin & Covishield at THESE prices

DGCI likely to grant market approval for Covaxin & Covishield at THESE prices - Details inside - The Central Drugs Standard Control Organisation's Subject Expert Committee suggested granting regular market approval to COVID-19 vaccines

India , Bharat , V-krishna-mohan , Prakash-kumar-singh , National-pharmaceutical-pricing-authority , Drugs-controller-general , Central-drugs-standard-control-organisation , Subject-expert-committee , Kumar-singh , Serum-institue , Bharat-biotech , Emergency-use-authorisation

Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval - Jammu Kashmir Latest News | Tourism

NEW DELHI, Jan 27: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India’s drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said. According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable. As of now, Covaxin is priced at Rs 1,200 […]

India , Bharat , V-krishna-mohan , Prakash-kumar-singh , National-pharmaceutical-pricing-authority , Expert-committee-on-covid , Central-drugs-standard-control-organisation-on , Subject-expert-committee , Central-drugs-standard-control-organisation , Kumar-singh , Serum-institue , Drugs-controller-general

Covishield, Covaxin likely to be capped at Rs 275 after approval

The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India’s drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said.According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to […]

India , Bharat , V-krishna-mohan , Prakash-kumar-singh , National-pharmaceutical-pricing-authority , Central-drugs-standard-control-organisation-on , A-subject-expert-committee , Subject-expert-committee , Central-drugs-standard-control-organisation , Kumar-singh , Serum-institue , Drugs-controller-general

Covishield, Covaxin dose to be capped at Rs 275 after getting market approval

The National Pharmaceutical Pricing Authority has been directed to start working towards capping the price to make the vaccines affordable, sources said.

India , Bharat , V-krishna-mohan , Prakash-kumar-singh , National-pharmaceutical-pricing-authority , Central-drugs-standard-control-organisation-on , A-subject-expert-committee , Subject-expert-committee , Central-drugs-standard-control-organisation , Kumar-singh , Serum-institue , Drugs-controller-general